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Mitochondrial oxidative stress is a common feature of skeletal myopathies across
multiple conditions; however, the mechanism by which it contributes to skeletal muscle
dysfunction remains controversial. Oxidative damage to proteins, lipids, and DNA has
received the most attention, yet an important role for reversible redox post-translational
modifications (PTMs) in pathophysiology is emerging. The possibility that these PTMs
can exert dynamic control of muscle function implicates them as a mechanism
contributing to skeletal muscle dysfunction in chronic disease. Herein, we discuss the
significance of thiol-based redox dependent modifications to mitochondrial, myofibrillar,
and excitation-contraction (EC) coupling proteins with an emphasis on how these
changes could alter skeletal muscle performance under chronically stressed conditions.
A major barrier to a better mechanistic understanding of the role of reversible redox PTMs
in muscle function is the technical challenges associated with accurately measuring the
changes of site-specific redox PTMs. Here we will critically review current approaches
with an emphasis on sample preparation artifacts, quantitation, and specificity. Despite
these challenges, the ability to accurately quantify reversible redox PTMs is critical to
understanding the mechanisms by which mitochondrial oxidative stress contributes to
skeletal muscle dysfunction in chronic diseases.
Keywords: redox signaling, post-translational modification, skeletal muscle, mitochondria, myofibrils,
glutathionylation
INTRODUCTION
Oxidative stress plays an important role in skeletal muscle health and disease. In the past, most
attention has been focused on skeletal muscle dysfunction caused by oxidative damage to proteins,
lipids, and DNA. This damage alters the structure of macromolecules in an irreversible manner and
requires turnover and production of new macromolecules to reverse the effects. However, there is
growing appreciation of the role of reactive oxygen and nitrogen species (ROS/RNS) in reversible
redox post-translational modifications (PTMs) in both muscle adaptation and the effects of chronic
disease and aging on skeletal muscle (Sohal and Orr, 2012). Normal skeletal muscle physiology
is characterized by transient periods of elevated ROS production due to contractile activity
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(Powers et al., 2010). In response to repeated bouts of contraction
these transient periods of elevated ROS production play an
important role in mediating the adaptive benefits of exercise
through activation of redox sensitive transcription factors
(Powers and Jackson, 2008). On the opposite extreme, chronic
elevation of oxidative stress underlies some of the pathological
changes associated with disuse atrophy (Min et al., 2011; Powers
et al., 2011).
In addition to these longer term adaptive changes in muscle,
it is now clear that the intracellular redox environment of
skeletal muscle also exerts dynamic control over skeletal muscle
physiology on the time scale of seconds to hours. Mild elevation
of oxidants increases skeletal muscle force production, while
further increases in oxidative stress reduce force and play a
role in skeletal muscle fatigue (Reid et al., 1993; Andrade et al.,
1998; Matuszczak et al., 2005). Manipulation of muscle oxidative
stress also induces rapid effects on mitochondrial energetics.
Within 24 h of treatment to induce a mild oxidative stress in
mice, paraquat impairs in vivo mitochondrial energetics and
induces an energy stress similar to that observed in aged skeletal
muscle (Siegel et al., 2012). Reducing mitochondrial oxidative
stress by treating with the mitochondrial targeted peptide SS-
31 has the opposite effect. Within 1 h of treatment with SS-
31 improved mitochondrial energetics and fatigue resistance
were associated with a more reduced GSH/GSSG redox state
in aged mouse skeletal muscle (Siegel et al., 2013). The rapid
and reversible nature of the control of this activity indicates
that these effects are not dependent on turnover of oxidatively
damaged molecules or protein translation, but rather are the
result of a more dynamic interaction between the redox
environment and skeletal muscle physiology (Figure 1), most
likely through reversible redox-dependent PTMs. In this review
we will highlight key mitochondrial, myofibrillar, and excitation-
contraction (EC) coupling proteins whose activities are modified
in a redox dependent manner and discuss the challenges and
recent developments in strategies to quantify redox PTMs.
SOURCES OF ROS IN SKELETAL MUSCLE
Skeletal muscle produces ROS from bothmitochondrial and non-
mitochondrial sources. During muscle contractile activity there
is an increase in muscle oxidant production. Mitochondria are
frequently cited as the primary source for oxidant production in
skeletal muscle. However, growing evidence supports a primary
role for non-mitochondrial oxidant by membrane bound
NADPH oxidases and, to a lesser extent, extracellular xanthine
oxidase production during muscle contraction (Gomez-Cabrera
et al., 2005; Frasier et al., 2013; Wadley et al., 2013; Alleman et al.,
2014; Sakellariou et al., 2014). In fact, recent work demonstrates
that under conditions of increased mitochondrial respiration,
as in working muscle, mitochondrial superoxide generation
is decreased compared to resting conditions (Anderson and
Neufer, 2006; Goncalves et al., 2015). NAD(P)H oxidase enzyme
complexes are found in the sarcoplasmic reticulum (SR), the
transverse tubules, and plasma membrane. Superoxide produced
by SR NAD(P)H oxidases has been implicated in regulation
of SR Ca2+ dynamics, while plasma membrane NAD(P)H
FIGURE 1 | Theoretical graph of the transient and additive nature of
reversible and irreversible redox PTMs in the context of skeletal
muscle physiology and disease. (A) Acute oxidative insults (shaded area)
can cause a swift and transient increase in reversible oxidative PTMs.
Irreversible PTMs rely on protein degradation and turnover, while most
reversible modifications can be cleared by the GSH/GSSG and Trx(red)/Trx(ox)
redox couples. Subsequent acute oxidative insults can be deleterious if the
modifications become irreversible, but this is not the case for reversible
modifications, which, can cause transcriptional activation of the antioxidant
response (adaptation, preconditioning, or hormesis) to suppress PTM
formation. (B) Chronic oxidative insults can result in an oxidized redox status
which persists throughout the duration of the stress. As with aging, many
metabolic and functional skeletal muscle defects that result from this oxidized
redox status can be rapidly reversed by restoring a more reduced redox
environment. In contrast, irreversible oxidative modifications, however, can
persist after the end of the oxidative insult.
oxidases, along with xanthine oxidase are the main contributors
of contraction induced extracellular superoxide production as
reviewed by Powers and Jackson (2008). This transient and
cyclical contraction induced ROS plays an important role in
regulating muscle contraction and inducing adaptive responses
to exercise in skeletal (McArdle et al., 2004; Ristow et al., 2009;
Powers et al., 2010) and cardiac muscle (Frasier et al., 2013).
In contrast, elevation of superoxide production associated
with chronic degenerative disease appears to be primarily
mitochondrial in origin. Mitochondrial superoxide or hydrogen
peroxide (H2O2) production is elevated in aging skeletal muscle
(Siegel et al., 2013), neurodegenerative disease (Manczak et al.,
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2011), cardiac pathology (Adlam et al., 2005; Dai et al., 2011a),
and following high fat diet. Reducing mitochondrial H2O2
production with either genetic or pharmacological interventions
targeted to the mitochondria reverses or protects against
mitochondrial deficits in these conditions (Dai et al., 2011b;
Siegel et al., 2013). The mitochondria contain several sites of
superoxide production associated with the electron transport
system (ETS) and tricarboxylic acid cycle. Complex I of the ETS
appears to be the dominant source of mitochondrial superoxide
under most conditions with contributions from complex II
and III increasing under conditions simulating more active
muscle (Goncalves et al., 2015). Complex I and II produce
superoxide in the matrix of the mitochondria, while complex III
generates superoxide on both sides of the inner mitochondrial
membrane (Goncalves et al., 2015). Multiple dehydrogenase
enzymes, including pyruvate dehydrogenase and oxoglutarate
dehydrogenase, also contribute to superoxide production in the
matrix (Mailloux et al., 2014a). Superoxide produced by the
mitochondria is rapidly converted to H2O2 by either MnSOD
(matrix) or CuZnSOD (inner membrane space). H2O2 then
interacts with the GSH-thioredoxin redox buffering system or is
rapidly decomposed to water and oxygen by the enzyme catalase
in the cytosol.
REDOX BUFFERING SYSTEM
Cellular redox status, as discussed in this review, is defined as
the relationship of ROS producers and scavengers. A common
method of determining the redox status of a cell is the reduced
to oxidized glutathione ratio (GSH:GSSG). Increasing evidence
suggests that redox regulation of cellular processes is the result
of signaling rather than non-specific oxidation (Matés et al.,
2008). H2O2, for example, interacts with the redox buffering
system through the GSH/GSSG and thioredoxin (Trxred/Trxox)
redox couples that are present in both the cytosolic and
mitochondrial matrix compartments. This redox system, for
which NADPH/NADP+ provides reducing power, transduces
information on the redox status to the cell by interacting
with the proteome through the thiol group on cysteine (Cys)
residues. Of the greater than 200,000 Cys residues present in
the proteome over 20,000 are thought to be redox sensitive,
meaning that they can undergo reversible redox modification as
described above (Jones and Go, 2011). The susceptibility of the
thiol groups on Cys residues, referred to as redox switches, to
oxidative modification varies according to their local biochemical
environment. The deprotonated thiol, the thiolate anion, is much
more susceptible to oxidation than the thiol group. The pKa of
thiols is high (>8); however, its proximity to positively charged
amino acids in proteins, arginine, and lysine, can function to
decrease their pKa values and make them more reactive at
physiological pH (Winterbourn and Hampton, 2008). Redox
PTMs of thiols are classified as reversible or irreversible, largely
depending on the degree of oxidation. The oxidation states of
a low pKa thiol (−2), for example, can be readily oxidized to
a reversible sulfenic acid (0) by a 2 electron oxidation with
H2O2, and subsequently to sulfinic (+2) and sulfonic acid (+4)
which are considered irreversible (Figure 2). These redox PTMs
can modify protein function by altering protein structure or
modifying interactions with other proteins, ligands, or DNA
(Forman et al., 2014).
THIOL-BASED REDOX PTMS
In addition to S-sulfenylation, S-nitrosylation (SNO) and S-
glutathionylation (SSG) are two of the most studied reversible
redox PTMs (Figure 2). These modifications have been well-
recognized as a fundamental mechanism of redox signaling by
modulating enzyme activities and protein functions in a variety of
cellular activities, such as signaling, metabolism, gene expression,
and apoptosis (Janssen-Heininger et al., 2008; Winterbourn and
Hampton, 2008; Brandes et al., 2009; Antelmann and Helmann,
2011). The types or levels of PTMs depend on the presence of
ROS and RNS, and the redox buffering system, and the enzymatic
reduction systems. Collectively, these modifications represent a
continuum that relates the form of modification to the extent
of ROS/RNS damage and functional consequence. However, our
FIGURE 2 | A simplified diagram of the formation of thiol redox PTMs. A reactive Cys can exist as thiolate anion under physiological pH. The thioate anion is
reactive with different ROS or RNS to form several types of reversible redox PTMs such as SNO, SSG, and SOH. SOH can be further oxidized into irreversible sulfinic
and sulfonic acid (Adapted from Filomeni et al. Cell Death and Differentiation 2005, Filomeni et al., 2005).
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current knowledge of redox PTMs and their significance is still
relatively limited due to the technical challenges associated with
the measurement of these labile modifications.
APPROACHES FOR MEASURING
REVERSIBLE REDOX PTMS
To measure endogenous redox PTMs, one of the major
challenges is how to preserve the modifications during
sample storage and prevent artificial oxidation during sample
preparation. There are two general processes of introducing
artifacts: (1) thiol oxidation by air through sample processing;
(2) reduction of PTMs by antioxidant enzymes during sample
storage or processing (Held and Gibson, 2012). Therefore,
special care and sample processing protocols are required
in order to accurately measure in vivo redox PTMs. To
minimize oxidation artifacts during cell or tissue processing,
two techniques are commonly applied. These are trichloroacetic
acid (TCA) quenching and cell lysis directly with a relative high
concentration of alkylation reagents, such as N-ethylmaleimide
(NEM) and iodoacetamide (IAA), to block free thiols (Leichert
and Jakob, 2006). TCA quenching is a fast process, which
can cause precipitation and denaturation of proteins, thus
suppressing reactivity of thiolate anions by lowering the pH
below their pKa. In contrast, alkylation with NEM and IAM
is applied to covalently block free thiols quickly, thus preserve
the redox PTMs for downstream processing and measurements.
NEM reacts with thiols via a faster and more specific Michael
addition reaction than the nucleophilic substitution reaction with
IAM. NEM is also less pH dependent compared to IAM, which
makes NEM often the preferred blocking reagents for measuring
redox PTMs. For measuring redox PTMs in tissues such as
muscle, a detailed optimization of tissue handling and processing
is particularly important to make sure that the endogenous PTMs
are well-preserved during this process.
Approaches for measuring redox PTMs include both indirect
and direct detection methods. Given the lack of direct detection
approaches of redox PTMs, the indirect approaches are still
a popular choice. Figure 3 illustrates the general chemistry
principles of most indirect and direct measurement approaches.
Basically, the free thiols are initially blocked by alkylation with
NEM in a denaturing buffer during tissue homogenization
or cell lysis. For indirect methods (Figure 3A), the different
types of redox PTMs are selectively reduced to free thiols by
using individual sets of reagents where ascorbate is commonly
used to reduce SNO (Derakhshan et al., 2007; Su et al.,
2013); a glutaredoxin (Grx) reduction cocktail for SSG (Shelton
et al., 2005; Zhang et al., 2011), and DTT for total reversible
oxidation (Leichert et al., 2008; Paulech et al., 2013). Then,
the pre-processed protein samples containing free thiols can be
subjected to different enrichment strategies and to either gel-
based or mass spectrometry (MS)-based approaches for profiling
redox PTM. It should be noted that the selective reduction
strategies used in most indirect detection methods are not perfect
in terms of specificity. For example, besides reducing SNO,
ascorbate is also reported to reduce disulfides in a certain degree
(Kuncewicz et al., 2003; Dahm et al., 2006). Similarly, even
with the use of mutated form of Grx to reduce its chance for
disulfide reduction, non-specific reduction of the Grx enzyme
cocktail was still observed (Su et al., 2014). In this regard,
the inclusion of proper negative or positive controls when
applying these indirect methods is important for more confident
identifications of endogenous redox modifications (Guo et al.,
2014a).
The concept of indirect detection of redox PTMs was
first reported as the biotin-switch technique (BST) for S-
nitrosylated proteins (Jaffrey and Snyder, 2001; Jaffrey et al.,
2001). This approach was also modified to detect other redox
PTMs including SSG (Lind et al., 2002; Reynaert et al.,
2006) and total reversible thiol oxidation (Leichert and Jakob,
2004). In this approach, the reduced thiols were labeled with
reagents containing a biotin tag and labeled proteins were
enriched by avidin affinity purification for biochemical (e.g.,
Western blotting) analyses. For example, redox differential in
gel electrophoresis (redox DIGE) allows the comparison of the
levels of oxidation between two samples on the same gel by
using iodoaceamido or maleimide-based cyanine fluorophores
(Leichert and Jakob, 2004; Hurd et al., 2007).
With the advances ofMS-based proteomics a number of liquid
chromatography-tandemmass spectrometry (LC-MS/MS)-based
proteomics approaches have been developed for identifying and
quantifying redox PTMs at the proteome level. For example,
in BST the biotinylated peptides (formerly SNO-modified) were
enriched by avidin chromatography and the biotin tags were
removed to allow the detection of SNO modified Cys sites (Hao
et al., 2006). Similarly, the OxICAT approach was developed
to measure the levels of total reversible thiol oxidation by
labeling the reduced and oxidized thiols with two versions of
alkylating ICAT (isotope-coded affinity tags) reagents (Leichert
et al., 2008). The differentially labeled thiols with ICAT are
purified by biotin-avidin purification and followed by LC-
MS/MS to quantify the levels of thiol oxidation on Cys residues
based on the light and heavy-labeled peptide intensity ratios.
Although the BST or biotin-based approaches are still popular,
these approaches generally suffer from the issue of non-
specific binding during enrichment. Alternatively, our laboratory
developed a resin-assisted capture (RAC) approach (originally
called quantitative cysteinyl-peptide enrichment technology, Liu
et al., 2004, 2005) for high-efficiency enrichment of cysteine-
containing peptides using Thiopropyl Sepharose 6B thiol-affinity
resin. More recently, we and others have demonstrated the
effectiveness of enriching several types of redox PTMs including
SNO, SSG, and total oxidation using this approach (Forrester
et al., 2009, 2011; Liu et al., 2010; Paulech et al., 2013; Su
et al., 2013, 2014; Guo et al., 2014a,b). Compared to the
biotin-based approaches, the resin-assisted procedure provides a
simpler workflow, a very high enrichment specificity (>95% of
peptides as Cys-peptides), better sensitivity than biotin avidin-
based enrichment as demonstrated by a side-by-side comparison
(Forrester et al., 2009). The RAC also provides the flexibility for
enabling multiplex quantification by allowing on-resin digestion
and isobaric labeling. For example, 4-plex (iTRAQ, isobaric tags
for relative and absolute quantification), 6-plex and 10-plex TMT
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FIGURE 3 | Schematic of the general approaches for measuring different reversible thiol-based redox PTMs. The free thiols are typically blocked by
alkylation with NEM as the initial step. (A) In the indirect methods, the different types of modified cysteines are selectively reduced to free thiols by using individual sets
of reagents. (B) In the direct methods, dimendone probe is often used to react with SOH, and organomercury resin for SNO. The reduced or labeled protein samples
are then subjected to enrichment and measurement by either gel-based or MS-based proteomic approaches.
(tandem mass tags) can be applied to enable MS-based site-
specific identification and quantification of redox PTMs across
4–10 biological conditions (Forrester et al., 2009; Su et al.,
2013, 2014; Guo et al., 2014a,b). More recently, a new isobaric
reagent iodoTMT that contains an iodoacetyl reactive group
was developed to directly label free thiols to enable multiplex
quantification of multiple redox PTMs (Pan et al., 2014; Qu et al.,
2014). In this approach, the labeled peptides are enriched by an
anti-TMT resin. Both the resin-assisted and iodoTMT approach
offer the flexibility of multiplexed quantification; however,
the resin-assisted approach should provide higher enrichment
specificity due to the covalent capture process compared to the
non-covalent immunoaffinity enrichment.
Besides the popular indirect methods, several direct
measurement strategies (Figure 3B) have been developed
for redox PTMs. For example, dimedone-based probes have been
shown to specifically label SOH (Charles et al., 2007; Leonard
et al., 2009). By incorporating a clickable dimedone probe with a
UV-cleavable biotin, MS-based global profiling of SOH modified
Cys sites was recently demonstrated (Yang et al., 2014, 2015). For
SNO, organomercury resin has recently been applied for direct
and site-specific identification of SNO-containing peptides by
first blocking the free thiols with MMTS and capturing SNO
directly by organomercury resin (Doulias et al., 2010, 2013;
Raju et al., 2015). Compared to indirect methods, the direct
measurement strategies are less prone to potential artifacts for
redox PTMs; however, to date the indirect approaches such as
RAC or iodoTMT still provide the most flexibility in multiplexed
quantification over many biological samples.
Besides these modifications shown on Figure 3, protein S-
sulfhydration (SSH) has recently been reported as a novel thiol-
based PTM similarly to SNO (Paul and Snyder, 2012). Amodified
version of the BST method was applied to detect proteins
modified by S-sulfhydration (Mustafa et al., 2009); however,
the blocking reagent MMTS (methyl methanethiosulfonate) was
shown to react with both free thiols and persulfides (Pan and
Carroll, 2013). More recently, a tag-switch assay was reported for
more specific SSH detection (Zhang et al., 2014). Further, studies
are necessary to validate the specificity and effectiveness of these
approaches for SSH modification.
In the study of redox PTMs, it is also important to be able to
be quantify the stoichiometry of redox PTMs (i.e., ratios oxidized
vs. reduced thiols) in order to better identify functionally
important Cys sites. To date, such measurements were only
demonstrated by a few approaches such as OxICAT (Leichert
et al., 2008; Knoefler et al., 2012) and the RAC approach coupled
with TMT (Guo et al., 2014b) in different biological systems.
This would be an important area of further development.
Furthermore, targeted quantification of redox PTMs by MS
is also an interesting development in its ability to perform
precise multiplexed quantification of many site-specific PTMs.
The proof-of-concept was demonstrated by coupling differential
alkylation of free/oxidized thiols using NEM and d5-NEM and
multiple reaction monitoring (MRM) to quantify site-specific
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Cys oxidation status of an endogenous protein p53 (Held et al.,
2010). The targeted quantification strategy should have a good
potential to complement Western blotting to verify redox PTMs
in specific proteins.
CONTROL OF PROTEIN STRUCTURE AND
FUNCTION BY REDOX PTMS
Changes in protein structure due to an oxidative environment,
can affect the localization, proteasome clearance, and the
function or activity of a protein depending on the site, type, and
extent of the oxidative modification. The formation of a disulfide
bond, for example, can affect the proteins tertiary structure,
making it a target for proteases. Many proteases have evolved
to target oxidatively modified proteins, thus turning over many
of the dysfunctional or structurally abnormal proteins (Jung
et al., 2013). Lon protease, for example, has been shown to
preferentially target oxidized mitochondrial aconitase in skeletal
muscle (Bota et al., 2002). However, heavily oxidized proteins,
like aconitase, can form aggregates and become inaccessible to
the proteasome (Bota and Davies, 2002). In muscle, creatine
kinase has been shown to be oxidative modified in aged mice,
resulting in protein aggregates and the loss of enzyme activity
(Nuss et al., 2009). Oxidative and other PTMs can have a direct
effect on protein function independent of structural changes.
Actin, for example, has many reported PTMs that affect its
polymerization, organization, and stability (Chung et al., 2013;
Terman and Kashina, 2013). These PTMs can form in an
enzyme active site with similar functional consequences as will
be discussed in this review.
A less recognized role of oxidative PTMs is their ability to
regulate the formation of other PTMs associated with normal
physiological signaling. This occurs primarily by oxidative
modification to a kinase or phosphatase, thus regulating its ability
to change the phosphorylation status of a protein. Increasing
evidence points to the significance of cross-talk between redox
and phosphorylation based signaling systems (Duhé et al., 1998;
Filomeni et al., 2005; Chiarugi and Buricchi, 2007; Kemble and
Sun, 2009). Indeed, oxidative modifications to the cysteine of
protein tyrosine phosphatases has been shown to suppress their
activity and lead to the increase in total phosphorylation (Rhee
et al., 2000). Intracellular redox circuitry is regarded as a master
regulator of phosphorylation and de-phosphorylation because
nearly all classes of protein phosphatases and many kinases
contain redox sensitive Cys residues for regulating their activities
(Chiarugi, 2005; Fisher-Wellman and Neufer, 2012). In general,
a shift in cellular redox state such as in aging (Sohal and Orr,
2012) would impact the activities of many phosphatases and
stress-sensitive Ser/Thr kinases (e.g., JNK/ASK1, IKKβ, NF-κB),
many of which are implicated in insulin resistance (Boura-Halfon
and Zick, 2009). Indeed, redox modulation of phosphatase
activity and phosphorylation in intact skeletal muscle has been
reported (Wright et al., 2009). Moreover, the redox regulation
of JNK activation and inactivation of MAP kinase phosphatase
(MKP-1) has been reported in cellular aging (Dasgupta et al.,
2010).
The changes in protein function and their ability to interact
with other proteins, macromolecules, and DNA, due to oxidative
PTMs is broadly termed redox signaling. However, this is
distinguishable from oxidative stress by the degree of oxidative
insult, the irreversibility (damage) associated with the PTM, and
the specificity of target (Schieber and Chandel, 2014). Aging
is an example of a progressive increase in oxidative stress
in which physiological redox signaling is disrupted. A redox
proteomic analysis has recently demonstrated that the cysteine
thiol proteome in aged mouse skeletal muscle is significantly
more oxidized than in young adult mice (McDonagh et al.,
2014). An important insight from this study was that the
number of cysteines that were either reversibly oxidized or
available for redox signaling, defined as being partially oxidized,
decreased in the aged muscles suggesting reduced flexibility of
the redox signaling system in aged muscle. Many mitochondrial
and myofibrillar proteins were among the proteins with redox
sensitive thiols detected in this study (McDonagh et al., 2014).
Below we discuss evidence for the modulation of activity for
many of these mitochondrial and myofibrillar proteins by redox
PTMs with an emphasis on SSG modification (Figure 4).
REDOX PTMS AND MITOCHONDRIAL
FUNCTION
Mitochondria are attractive targets for redox control. As
discussed above, the mitochondria are an important source
of superoxide and H2O2 production in the cell. Therefore,
modulation of cell energetics and function by direct control
over mitochondrial function by redox PTMs would co-localize
the source and targets of oxidant production and allow rapid
cellular response to changes in redox status. Mitochondria
also contain high concentrations of glutathione and an
active thioredoxin (Trx)/GSH redox buffering system that
would facilitate translation of oxidative stress to redox PTMs.
Finally, many mitochondrial proteins, such as 2-oxoglutarate
dehydrogenase, isocitrate dehydrogenase, Complex I, and
glutaredoxin isoforms 1 and 2, have conserved cysteine
residues associated with dehydrogenase or redox transfer
reactions (Mailloux et al., 2014a). Dynamic interaction
between mitochondrial respiration and redox biology has
been demonstrated in isolated mitochondria, muscle cells, and
in vivo. Electron flux through the ETS plays an important
role in regulating mitochondrial redox status due to the
important role of electron flux in controlling NADH/NAD
and NADPH/NADP and thus reducing power. An oxidized
GSH/GSSG ratio was observed in isolated brain mitochondria
under low mitochondrial respiration (rotenone, antimycin A, or
no ADP) compared to state 3 respiration (ADP and substrates),
however, the GSH/GSSG ratio of freshly isolated mitochondria
in the absence of respiratory substrates was more oxidized
than either condition (Garcia et al., 2010). The more oxidized
GSH/GSSG state was associated with increased protein SSG of
several mitochondrial proteins. In a separate study, increases
in SSG of mitochondrial proteins reduced basal mitochondrial
ATP-linked oxygen consumption as well as mitochondrial
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FIGURE 4 | EC coupling and bioenergetics network in a reduced (high GSH:GSSG ratio) and oxidative (low GSH:GSSG ratio) redox environment. Ca2+
handling by the SR and the ATP generated by the mitochondria are the primary substrates of myofibril contraction. Oxidative PTM can affect the mitochondrial
efficiency as well as EC coupling during redox signaling and the oxidative stress associated with disease. Protein S-Glutathioylation of critical mitochondrial, SR, and
myofibrillar proteins are depicted as well as the primary sources of H2O2.
reserve capacity in a dose-dependent and reversible manner in
smooth muscle cells (Hill et al., 2010). This dynamic interaction
between redox status and mitochondrial function also translates
to in vivo energetics in skeletal muscle. Treatment with paraquat
inhibited in vivo resting mitochondrial ATPase rate and maximal
ATP production within 24 h in aged mice in the absence of
changes in mitochondrial protein expression or accumulation
of 4-Hydroxynonenal as a marker of oxidative damage (Siegel
et al., 2012). Support for an important role of redox regulation
of energetics in skeletal muscle pathology also comes from the
reversal of mitochondrial deficits in aging muscle following
treatment with the mitochondrial targeted peptide SS-31 to
reduce mitochondrial oxidant production. One hour after
treatment SS-31 increased mitochondrial coupling ratio (P/O)
and maximal ATP production (Siegel et al., 2013). This was
associated with a more reduced GSH/GSSG ratio in the treated
aged muscles. The absence of an observed effect of this treatment
in the young muscles or in permeabilized muscle fibers from the
treated aged mice suggests that the inhibition of function that
was reversed by SS-31 was dependent the interaction between
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the more oxidized cell environment in the aged muscle and the
mitochondria.
Protein SSG of an oxidized cysteine (sulfenic acid), which can
be reversed by glutaredoxin, prevents the irreversible oxidation
to sulfinic (-SO2H) or sulfonic (-SO3H) acid. In the case of
complex I, irreversible oxidation results in loss of enzyme
activity (Hurd et al., 2008). Thus, reversible PTMs can serve
as a protective modification during transient oxidative stress.
The prevention of further oxidation by SSG was suggested as
a mechanism to explain the protective effect of elevated Grx2
expression on doxorubicin-induced cardiotoxicity (Diotte et al.,
2009). This study was unique in demonstrating increased SSG
of mitochondrial proteins with overexpression of Grx2 under
both normal and doxorubicin exposed conditions (Diotte et al.,
2009). In contrast, other studies have demonstrated that reduced
expression of Grx2 resulted in increased SSG of complex I in the
human eye (Liu et al., 2015) and mouse heart (Mailloux et al.,
2014b).
In addition to protecting against further oxidation, SSG can
also modify protein function. Complex I is one of the most well-
studied mitochondrial proteins in terms of redox regulation of
activity. The attention given to complex I is likely due in part to
its position as the entry point for electrons into the ETS from
NADH and its role as a major source of ETS derived superoxide.
Therefore, it plays a key role in regulatingmitochondrial function
and is the complex most commonly implicated in mitochondrial
diseases associated with genetic, idiopathic, and lifestyle. Of the
130 cysteine residues contained in the 45 subunits of complex
I, 30 were sensitive to reversible oxidation following diamide
treatment in mitochondria isolated from brain (Danielson et al.,
2011). Six of these residues in brain mitochondria were sensitive
to reversible oxidation in vivo following depletion of GSH
with buthionine sulphoximine (BSO). Two of these residues,
cys-531 and 704 on the Ndufs1 subunit were also found to
be oxidized in oxidatively stressed bovine hearts (Hurd et al.,
2008).
Increased SSG of complex I in heart mitochondria by diamide
treatment (Hurd et al., 2008) or by knocking out Grx2 (Mailloux
et al., 2014b) leads to reversible inhibition of complex I activity.
However, other groups report that the inhibition of complex
I activity by SSG was only partially reversible when oxidized
under severe oxidizing conditions, suggesting that the SSG may
have initiated structural modifications or protein interactions
of complex I that were less reversible than the PTM itself
(Taylor et al., 2003). Despite the inhibition of complex I
NADH reducing activity, SSG of complex I results in elevated
superoxide production which is converted to H2O2 in the intact
mitochondria (Taylor et al., 2003). The elevation of superoxide
production occurs much more rapidly than inhibition of NADH
reducing activity and was acutely reversible with exposure to
a reducing agent suggesting that these two effects of SSG on
complex I function have different biochemical mechanisms.
These functional effects suggest a model whereby an initial
disturbance in redox balance could initiate SSG of complex I
leading to further oxidation of the mitochondrial environment
and inhibition of mitochondrial ATP production, as well as other
targets discussed below.
In addition to complex I, the activities of several other
proteins involved in oxidative phosphorylation are modified
by reversible redox PTMs. F1FO ATPase is another target of
redox PTM in the mitochondria. In heart mitochondria disulfide
formation and SSG are elevated at Cys 294 on the alpha
subunit of the F1 complex, while S-nitrosylation is reduced,
in dyssynchronous heart failure (Wang et al., 2011). Cardiac
resynchronization therapy that improves cardiac function also
reverses the redox PTM at this site. Working with brain and
liver mitochondria, Garcia et al demonstrated F1FO ATPase
was S-glutathionylated in response to changing mitochondrial
GSH/GSSG ratios induced by altering the respiratory state of the
mitochondria (Garcia et al., 2010). The increased SSG associated
with low respiratory flux reversibly inhibited ATPase activity
(Garcia et al., 2010). The supply of reducing equivalents to
the respiratory chain can also be modified by redox PTMs.
Succinyl CoA transferase (Garcia et al., 2010) and alpha-
ketoglutarate dehydrogenase (Applegate et al., 2008) are also
reversibly inhibited by SSG in brain and heart mitochondria,
respectively. Alpha ketoglutarate dehydrogenase is an NADH
generating step in the Kreb’s cycle thus inhibition of this enzyme
and complex I would reduce mitochondrial capacity by both
directly inhibiting the supply of NADH and the entry of NADH
into the ETS.
SSG may also exert control over bioenergetics by controlling
the coupling of electron transport to ATP generation through
the membrane potential. A high potential across the inner
mitochondrial membrane under low flux or reductive stress
leads to elevated mitochondrial superoxide production (St-Pierre
et al., 2002; Nicholls, 2004). Uncoupling proteins 2 and 3 (UCP2
and UCP3) serve as part of the antioxidant defense system by
facilitating proton leak across the innermitochondrial membrane
and dissipating the membrane potential to reduce mitochondrial
superoxide production (Echtay et al., 2002; Echtay and Brand,
2007). It has been known for several years that oxidative stress
induces increased proton leak through UCP3 (Echtay et al.,
2002; Echtay and Brand, 2007). Recently Harper and colleagues
demonstrated that this proton leak is under the control of the SSG
state of Cys 25 and Cys 259 (Mailloux et al., 2011). In contrast
to other examples of redox PTM of mitochondrial proteins,
where increased SSG is associated with an oxidized GSH/GSSG
status, UCP3 appears to be deglutathionylated directly by
GRx1 under high oxidative stress conditions (Mailloux et al.,
2011). Deglutathionylation of UCP3 led to an increase in state
4 (non-phosphorylating respiration) in mitochondria isolated
from skeletal muscle, while treatment with diamide to increase
SSG had the opposite effect. Glutathionylation state had a
similar effect on the control of UCP2-mediated proton leak in
mitochondria from mouse kidney and thymocytes (Mailloux
et al., 2011).
Other proton leak pathways may also be regulated by
reversible PTMs. The adenine nucleotide transporter (ANT)
also plays an important role in regulating mitochondrial ROS
production through control of the membrane potential (Brand
et al., 2005). There is some evidence that the ANT activity is also
affected by SSG (Queiroga et al., 2010), although the evidence
for this is not as strong as for other mitochondrial proteins.
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Modulation of ANT function by redox PTM would provide
another route by which the redox status could feedback and
control both mitochondrial redox state and energy metabolism
of the mitochondria. Thus, SSG of proteins involved in oxidative
phosphorylation may represent a dynamic reversible response
of the mitochondria to minimize the production of superoxide
by the mitochondria or irreversible damage under periods of
elevated oxidative stress, such as conditions of low respiratory
flux, high reductive stress (high fat feeding), or intermittent
exercise (Anderson et al., 2007, 2009). As noted above, SSG
can provide a defense against excess mitochondrial superoxide
production by modifying the supply of reducing equivalents to
the ETS, electron flux through the ETS, and the membrane
potential of the mitochondria. However, under conditions of
sustained oxidative stress such as chronic disease or aging,
these same responses may contribute to mitochondrial energetic
deficits and contribute to tissue dysfunction. This suggests that
directly altering the redox environment of the mitochondria may
be an effective strategy to rapidly improve muscle mitochondrial
energetics in the context of chronic disease (Marcinek and Siegel,
2013; Siegel et al., 2013).
It has also been suggested that mitochondrial dynamics,
at the level of mitochondrial ultrastructure, are controlled
by redox signaling within a cell, which has a direct impact
on mitochondrial function (Willems et al., 2015). In C2C12
myocytes, the change in mitochondrial morphology associated
with H2O2 and possibly exercise, is thought to be due
to mitochondrial depolarization (Fan et al., 2010), however,
increasing evidence of oxidative modifications of mitochondrial
fission and fusion proteins (Drp1, Mfn1, Mfn2, and OPA1)
suggests redox PTMs may be responsible for regulating
mitochondrial dynamics in oxidative environments (Willems
et al., 2015). In elderly subjects with a markedly low
muscle function, OPA1 protein, mitochondrial respiration and
cytochrome c oxidase activity, as well as PGC-1α and Sirt3
protein content were decreased compared to young subjects,
suggesting that muscle dysfunction with aging is significantly
correlated with changes in mitochondrial function, dynamics,
and biogenesis (Joseph et al., 2012).
REDOX PTMS AND MUSCLE FORCE
GENERATION
The important interaction between ROS, redox status, and
muscle force production and fatigue is well-established.
Depletion of basal levels of oxidants in resting muscle reduces
maximal force, while small elevation of ROS can enhance muscle
force production (Reid et al., 1993; Andrade et al., 1998). Several
reports have also shown that ROS contribute to muscle fatigue,
especially during repetitive submaximal contractions (Reid
et al., 1994; Matuszczak et al., 2005). Experimental evidence
suggests that ROS may exert their greatest effect on muscle
contraction through altering E-C coupling or Ca2+ sensitivity of
the myofibril (Moopanar and Allen, 2005, 2006), although recent
evidence suggests a role for redox PTMs in muscle stiffness
(Alegre-Cebollada et al., 2014). Despite the well-established
role for redox modulation of muscle contraction, the specific
molecular targets for redox modification are less well-defined.
Below we discuss recent evidence for effect of redox PTMs on
activity of specific E-C coupling and myofibrillar proteins.
Redox modifications of some components of the myofibril
appear to be dependent on the contractile state of the protein.
This has been hypothesized to be due to structural changes
in the proteins that either bury or expose cysteine residues to
the cytosolic environment (Gross and Lehman, 2013; Alegre-
Cebollada et al., 2014). When cardiac myofibrils were exposed to
cysteine oxidizing reagents under rigor, basal myofibrillar ATPase
rates were significantly higher than controls, but there was no
effect on maximal ATPase activity (Gross and Lehman, 2013).
In contrast, myofibrils exposed under relaxing conditions have
a significantly lower maximal ATPase activity with no effect on
the basal rate. The reduced ATPase rate in the resting condition
was associated with increased cysteine oxidation of the myosin
heavy chain compared to control and rigor. These effects were
similar for different oxidative modifications induced by NEM,
SNAP, and DTDP suggesting that the type of modification to the
MHC thiols may not be critical for the effect on ATPase activity.
Redox modifications of titin also appear to be determined by
changes in protein structure (Alegre-Cebollada et al., 2014). Titin
is an approximately 3000 kD protein that stretches between the
M-line and Z-line and anchors the thick filament of the myofibril
to the z-line. It has a highly coiled structure at rest that is
stretched during lengthening of striated muscle sarcomeres (Tan
et al., 1993). This stretching provides stability and elasticity. Titin
has multiple cysteine residues that are buried on the interior of
the protein under relaxed conditions, but are exposed during
stretching. Alegre-Cebollada et al found that stretching the
protein made these cysteines susceptible to SSG which prevented
its refolding and modulated the elasticity of cardiac sarcomeres
(Alegre-Cebollada et al., 2014). Similarly, increased mechanical
stability of titin caused by disulfide bond formation within the
cardiac-specific N2-Bus region of the protein is believed to result
in the passive stiffness in human heart myofibrils under oxidizing
conditions (Grützner et al., 2009). This reduced elasticity of titin
by reversible PTM may contribute to impaired relaxation and
diastolic dysfunction under conditions of chronic oxidative stress
such as aging.
Redox PTMs may affect muscle force production by
modulating both Ca2+ dynamics and Ca2+ sensitivity of the
myofiber. Redox proteomic analysis indicates that both alpha
and beta isoforms of tropomyosin can undergo reversible redox
modification as well as Troponin I, Myosin light chain 1/3,
Myosin regulatory light chain 2, and Myosin-4(McDonagh et al.,
2014). Following myocardial infarction or ischemia reperfusion
in pig, mice, and rats, Cys190, the only cardiac tropomyosin
cysteine, showed significant oxidation and was at least partly
implicated in the resulting contractile dysfunction by a H2O2
dependent mechanism (Canton et al., 2004, 2006; Avner et al.,
2012).
The effects of redox modulation on Ca2+ release from the SR
by RyR and reuptake by SERCA may be the most well studied
effects of redox PTMs on muscle function. Ca2+ reuptake into
the SR by the SERCA proteins determines the rate of relaxation
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of muscle and the ability to sustain repeated muscle contractions.
In the mouse heart, SERCA Cys 674 glutathionylation resulted
in increased activity; however, irreversible sulfonation resulted
in decreased Ca2+ reuptake and relaxation and was prevented
by catalase overexpression (Tong et al., 2010; Qin et al., 2013).
Similarly, treatment of rat ventricular myocytes with H2O2
resulted in SR Ca2+ depletion due to SERCA oxidative inhibition
and the oxidative activation of Na+/Ca2+-Exchanger (Kuster
et al., 2010).
Ca2+ release from the SR by RyR is also affected by the
oxidation state of its cysteine residues. Stamler et al demonstrated
that RyR has multiple cysteine residues that have different
levels of susceptibility to oxidation (Sun et al., 2013). Under
high pO2 conditions to induce an oxidative stress, cysteine
residues in regions of the protein that interact with the L-
Type Ca2+ channel form disulfide bonds, which may disrupt
the interaction of the RyR with this protein. Interaction with
the L-type Ca2+ channel is responsible for Ca2+ induced Ca2+
release and disruption of this interaction by thiol oxidation may
inhibit full Ca2+ release from the SR. Marks and colleagues have
also found disruption of the calstabin 1- RyR interaction by
both reversible and irreversible PTMs in aged skeletal muscles
(Umanskaya et al., 2014) and heart failure (Rullman et al.,
2013). This oxidation was prevented by reducing mitochondrial-
derived oxidative stress with mitochondrial-targeted catalase
expression. Destabilization of the calstabin-1-RyR interaction
led to increased open probability of the RyR and greater Ca2+
leak from the SR. This chronic leak reduced the Ca2+ released
from the SR and therefore muscle force production upon
muscle stimulation in aging muscle. The chronic Ca2+ leak
induced by RyR oxidation also induces a feedforward cycle by
increasing mitochondrial oxidative stress and muscle atrophy
due to increased mitochondrial Ca2+ uptake. Both of these
effects in aging muscle were reduced in aged mice overexpressing
mitochondrial targeted catalase to reduce oxidative stress
(Umanskaya et al., 2014).
CONCLUSIONS
Skeletal muscle physiology is determined by EC coupling,
myofibrillar force production, and bioenergetics. In this review
we have highlighted how each of these processes can be
acutely controlled by changes in redox homeostasis through
reversible redox sensitive PTMs. These redox PTMs provide a
mechanism for cells to rapidly respond to redox changes to
prevent irreversible oxidative damage, modulate protein activity
or signal adaptive responses to stress. The GSH/GSSG and
thioredoxin systems provide the biochemical link between the
cellular redox environment and protein thiol groups. Thus,
reversible thiol modifications provide a mechanism for cells
to rapidly respond to redox changes, which during transient
stress can serve important signaling or cell-protective roles
by altering protein function. However, under conditions of
chronic redox stress that create conditions, where these normally
transient modifications persist, these same signaling or protective
responses can inhibit cell function and lead to pathology.
We have attempted to highlight some potential targets in the
skeletal muscle mitochondria, E-C coupling and myofibrillar
systems where persistent redox sensitive PTMs may contribute
to muscle pathology in chronic diseases and aging. In the
mitochondria it is becoming increasingly clear that redox PTMs
exert control over both entries of electrons into the ETS as well
as flux through the system, thereby dynamically influencing both
mitochondrial energetics and oxidative stress. These changes
to the mitochondria can then feedforward to influence redox
PTMs on E-C coupling and myofibrillar proteins to influence
Ca2+ sensitivity, relaxation, and force production (Figure 4).
Thus, reversible redox PTMs provide a mechanism by which
the mitochondria can influence muscle force production that is
parallel to, and in some ways, independent of changes in ATP
flux. Another important point is that because these changes
rapidly respond to changes in the redox environment of the
cell they may provide a mechanism to rapidly reverse functional
deficits in muscle performance associated chronic disease. We
are relatively early in our mechanistic understanding of the
contribution of redox PTMs to skeletal muscle dysfunction in
chronic disease. As interest continues to grow and technical
challenges to the quantitative measurements of these changes
in vivo are overcome we expect that this area will lead to new
insights into the mechanisms of skeletal muscle dysfunction and
identify exciting new directions for development of interventions
to improve quality of life in this growing patient population.
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